市場調查報告書
商品編碼
1003424

消費者基因學的全球市場:各應用領域(遺傳的相關性,祖先,生殖健康,診斷),各地區(北美,歐洲,APAC,南美,MEA)的市場規模,佔有率及趨勢分析,各市場區隔預測(2021年∼2028年)

Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Reproductive Health, Diagnostics), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2021 - 2028

出版日期: | 出版商: Grand View Research, Inc. | 英文 150 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球消費者基因學的市場規模,預計從2021年到2028年以19.4%的年複合成長率擴大,到2028年達到81億美元。

遺傳基因研究的技術進步,使用遺傳基因基礎的檢驗,有助於醫生與消費者之間提高意識。

DNA檢驗相關的意識高漲使採用率提高,這為在家庭環境中進行DNA測試提供了健康的成長前景。

本報告提供全球消費者基因學市場相關調查分析,市場及產業預測,各市場區隔、各地區的預測,加上競爭情形相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查手法

第3章 消費者基因學市場變數,趨勢,及範圍

  • 市場細分化和範圍
  • 應用的滲透與成長預測的製圖,2020年
  • 全球消費者基因學市場-各要因的SWOT分析(政治及法律,經濟及技術性)
  • 產業分析-波特的五力分析

第4章 各應用領域市場估計、趨勢分析

  • 市場:應用的動向分析
  • 遺傳的相關性
  • 診斷
  • 生活方式,健康,營養
  • 祖先
  • 生殖健康
  • 個體化醫療及藥物遺傳學檢驗
  • 運動營養、健康
  • 其他

第5章 各地區市場的估計、趨勢分析

  • 各地區市場佔有率,2020年及2028年
  • 2020年的各地區的普及與成長預測的製圖
  • 北美
    • 美國
  • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 新加坡
  • 南美
    • 巴西
    • 墨西哥
  • 中東、非洲(MEA)
    • 南非
    • 沙烏地阿拉伯

第6章 競爭情形

  • 策略架構
  • 市場進入的分類
  • 企業簡介
    • Ancestry
    • 23andMe, Inc.
    • Gene By Gene, Ltd. (FamilyTree DNA)
    • Mapmygenome
    • Color Genomics, Inc.
    • Positive Biosciences, Ltd.
    • Futura Genetics
    • Helix OpCo LLC
    • MyHeritage Ltd.
    • Pathway Genomics
    • Veritas
    • Myriad Genetics, Inc.
    • Illumina, Inc.
    • Amgen, Inc.
    • Xcode Life
    • Diagnomics, Inc.
    • Toolbox Genomics
目錄
Product Code: GVR-2-68038-987-6

Consumer Genomics Market Growth & Trends

The global consumer genomics market size is projected to reach USD 8.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.4% from 2021 to 2028. Technological advances in genetic research have helped to raise awareness among physicians as well as consumers pertaining to the use of gene-based testing.

Genomics testing enables the determination of common traits by studying a DNA molecule, predictions about health, and offers evidence of a person's ancestry. Several companies are providing DNA tests directly to customers by which they have access to their genetic information without involving the healthcare professional. Rising awareness about DNA testing has driven the adoption rate, which in turn provides healthy growth prospects for the implementation of DNA tests in home settings.

The continuously declining costs of genotyping have resulted in direct-to-consumer services becoming more accessible to the average consumer as DNA testing services are delivered by key companies. Many key participants are focusing majorly on building partnerships and collaborations with physicians and healthcare systems to inflate their current marketplace.

Consumer Genomics Market Report Highlights

The genetic relatedness segment accounted for the largest revenue generation in 2020 and is anticipated to remain dominant throughout the forecast period

Genetic relatedness involves the determination of hereditary or the genetic transfer of traits from parents to their offspring

These tests help analyze repetitive DNA regions known as short tandem repeats for the determination of a likelihood of paternity

The lifestyle, wellness, and nutrition segment is expected to witness the fastest CAGR as consumer genomics tests are claimed to provide personalized nutrition based on an individual's genotype

For patients with rare genetic disorders such as galactosemia and lactose intolerance, a customized diet is recommended

Growing public interest for personalized health has fueled the adoption of nutrigenetic testing services, specifically for optimizing nutrition

Hence, personalized nutrition is employed to maintain or improve health by using genetic, clinical, and dietary information to provide precise and more efficacious personalized healthy recommendations

North America is estimated to capture the largest market share owing to the local presence of key industry participants such as 23andMe and AncestryDNA, and the commercialization of FDA approved kits

Due to growing investments and skills, in Asia Pacific, the market is expected to grow with the fastest CAGR

This can majorly be attributed to the advent of knowledge-based innovations and entry of investors focused on personalized genetic screening as well as the presence of research funding agencies

Table of Contents

Chapter 1 Executive Summary

  • 1.1 Market Snapshot

Chapter 2 Research Methodology

  • 2.1 Information Procurement
    • 2.1.1 Purchased Database
    • 2.1.2 GVR's Internal Database
  • 2.2 Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Approaches for Market Estimation
    • 2.4.1 Approach 1: Commodity Flow & Bottom-Up Approach
    • 2.4.2 Approach 2: Top-Down and Parent Market Analysis

Chapter 3 Consumer Genomics Market Variables, Trends, & Scope

  • 3.1 Market Segmentation & Scope
    • 3.1.1 Market driver analysis
      • 3.1.1.1 Rise in the interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
      • 3.1.1.2 Increase in access to DTC services due to reducing the cost of genotyping
      • 3.1.1.3 Expansion in applications of DTC genetics
      • 3.1.1.3.1 Health testing
      • 3.1.1.3.2 Ancestry
      • 3.1.1.3.3 Genetic relatedness
      • 3.1.1.4 Significant investments & initiatives by companies to maintain their competitive edge in the market
      • 3.1.1.5 Growing trend of personalized genomics
    • 3.1.2 Market restraint analysis
      • 3.1.2.1 Ethical and clinical issues about the use of DTC products & personalized treatment
      • 3.1.2.2 Misleading results create challenges in the adoption of home-based genetic tests
      • 3.1.2.3 Regulatory challenges about the use of DTC genetic tests
  • 3.2 Penetration & Growth Prospect Mapping For Application, 2020
  • 3.3 Global Consumer Genomics Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.4 Industry Analysis - Porter's

Chapter 4 Consumer Genomics Market Categorization: Application Estimates & Trend Analysis

  • 4.1 Market: Application Movement Analysis
  • 4.2 Genetic Relatedness
    • 4.2.1 Market for genetic relatedness, 2017 - 2028 (USD Million)
  • 4.3 Diagnostics
    • 4.3.1 Market for diagnostics, 2017 - 2028 (USD Million)
  • 4.4 Lifestyle, Wellness, & Nutrition
    • 4.4.1 Market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
  • 4.5 Ancestry
    • 4.5.1 Market for ancestry, 2017 - 2028 (USD Million)
  • 4.6 Reproductive Health
    • 4.6.1 Market for reproductive health, 2017 - 2028 (USD Million)
  • 4.7 Personalized Medicine & Pharmacogenetic Testing
    • 4.7.1 Market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
  • 4.8 Sports Nutrition & Health
    • 4.8.1 Market for sports nutrition & health, 2017 - 2028 (USD Million)
  • 4.9 Others
    • 4.9.1 Market for others, 2017 - 2028 (USD Million)

Chapter 5 Consumer Genomics Market Categorization: Regional Estimates & Trend Analysis

  • 5.1 Market Share By Regional, 2020 & 2028
  • 5.2 Penetration & Growth Prospect Mapping For Region, 2020
  • 5.3 North America
    • 5.3.1 Market, 2017 - 2028 (USD Million)
    • 5.3.2 U.S.
      • 5.3.2.1 Market, by application, 2017 - 2028 (USD Million)
  • 5.4 Canada
      • 5.4.1.1 Market, by application, 2017 - 2028 (USD Million)
  • 5.5 Europe
    • 5.5.1 Market, 2017 - 2028 (USD Million)
    • 5.5.2 Germany
      • 5.5.2.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.5.3 U.K.
      • 5.5.3.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.5.4 France
      • 5.5.4.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.5.5 Italy
      • 5.5.5.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.5.6 Spain
      • 5.5.6.1 Market, by application, 2017 - 2028 (USD Million)
  • 5.6 Asia Pacific
    • 5.6.1. Market, 2017 - 2028 (USD Million)
    • 5.6.2 Japan
      • 5.6.2.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.6.3 China
      • 5.6.3.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.6.4 Australia
      • 5.6.4.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.6.5 India
      • 5.6.5.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.6.6 Singapore
      • 5.6.6.1 Market, by application, 2017 - 2028 (USD Million)
  • 5.7 Latin America
    • 5.7.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.7.2 Brazil
      • 5.7.2.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.7.3 Mexico
      • 5.7.3.1 Market, by application, 2017 - 2028 (USD Million)
  • 5.8 Middle East & Africa (MEA)
    • 5.8.1 MEA consumer genomics market, 2017 - 2028 (USD Million)
    • 5.8.2 South Africa
      • 5.8.2.1 Market, by application, 2017 - 2028 (USD Million)
    • 5.8.3 Saudi Arabia
      • 5.8.3.1 Market, by application, 2017 - 2028 (USD Million)

Chapter 6 Consumer Genomics Market: Competitive Landscape

  • 6.1 Strategy Framework
  • 6.2 Market Participant Categorization
  • 6.3 Company Profiles
    • 6.3.1 Ancestry
      • 6.3.1.1 Company overview
      • 6.3.1.2 Financial performance
      • 6.3.1.3 Product benchmarking
      • 6.3.1.4 Strategic initiatives
    • 6.3.2 23andMe, Inc.
      • 6.3.2.1 Company overview
      • 6.3.2.2 Financial performance
      • 6.3.2.3 Product benchmarking
      • 6.3.2.4 Strategic initiatives
    • 6.3.3 Gene By Gene, Ltd. (FamilyTree DNA)
      • 6.3.3.1 Company overview
      • 6.3.3.2 Financial performance
      • 6.3.3.3 Product benchmarking
      • 6.3.3.4 Strategic initiatives
    • 6.3.4 Mapmygenome
      • 6.3.4.1 Company overview
      • 6.3.4.2 Financial performance
      • 6.3.4.3 Product benchmarking
      • 6.3.4.4 Strategic initiatives
    • 6.3.5 Color Genomics, Inc.
      • 6.3.5.1 Company overview
      • 6.3.5.2 Financial performance
      • 6.3.5.3 Product benchmarking
      • 6.3.5.4 Strategic Initiatives
    • 6.3.6 Positive Biosciences, Ltd.
      • 6.3.6.1 Company overview
      • 6.3.6.2 Financial performance
      • 6.3.6.3 Product benchmarking
      • 6.3.6.4 Strategic initiatives
    • 6.3.7 Futura Genetics
      • 6.3.7.1 Company overview
      • 6.3.7.2 Financial performance
      • 6.3.7.3 Product benchmarking
      • 6.3.7.4 Strategic initiatives
    • 6.3.8 Helix OpCo LLC
      • 6.3.8.1 Company overview
      • 6.3.8.2 Financial performance
      • 6.3.8.3 Product benchmarking
      • 6.3.8.4 Strategic initiatives
    • 6.3.9 MyHeritage Ltd.
      • 6.3.9.1 Company overview
      • 6.3.9.2 Financial performance
      • 6.3.9.3 Product benchmarking
      • 6.3.9.4 Strategic initiatives
    • 6.3.10 Pathway Genomics
      • 6.3.10.1 Company overview
      • 6.3.10.2 Financial performance
      • 6.3.10.3 Product benchmarking
      • 6.3.10.4 Strategic initiatives
    • 6.3.11 Veritas
      • 6.3.11.1 Company overview
      • 6.3.11.2 Financial performance
      • 6.3.11.3 Product benchmarking
      • 6.3.11.4 Strategic initiatives
    • 6.3.12 Myriad Genetics, Inc.
      • 6.3.12.1 Company overview
      • 6.3.12.2 Counsyl Inc.
      • 6.3.12.2.1 Company overview
      • 6.3.12.3 Financial performance
      • 6.3.12.4 Product benchmarking
      • 6.3.12.5 Strategic initiatives
    • 6.3.13 Illumina, Inc.
      • 6.3.13.1 Company overview
      • 6.3.13.2 Financial performance
      • 6.3.13.3 Product benchmarking
      • 6.3.13.4 Strategic initiatives
    • 6.3.14 Amgen, Inc.
      • 6.3.14.1 Company overview
      • 6.3.14.2 deCODE genetics
      • 6.3.14.2.1 Company overview
      • 6.3.14.3 Financial performance
      • 6.3.14.4 Product benchmarking
      • 6.3.14.5 Strategic initiatives
    • 6.3.15 Xcode Life
      • 6.3.15.1 Company overview
      • 6.3.15.2 Financial performance
      • 6.3.15.3 Product benchmarking
      • 6.3.15.4 Strategic initiatives
    • 6.3.16 Diagnomics, Inc.
      • 6.3.16.1 Company overview
      • 6.3.16.2 Financial performance
      • 6.3.16.3 Product benchmarking
      • 6.3.16.4 Strategic initiatives
    • 6.3.17 Toolbox Genomics
      • 6.3.17.1 Company overview
      • 6.3.17.2 Financial performance
      • 6.3.17.3 Product benchmarking
      • 6.3.17.4 Strategic initiatives

List of Tables

  • TABLE 1 Concerns related to unaccredited online DTC genetic testing:
  • TABLE 2 North America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 3 U.S. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 4 Canada consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 5 Europe consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 6 Germany consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 7 U.K. consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 8 France consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 9 Italy consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 10 Spain consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 11 Asia Pacific consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 12 Japan consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 13 China's top providers of sequencing servicers:
  • TABLE 14 China consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 15 Australia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 16 India consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 17 Singapore consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 18 Latin America consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 19 Brazil consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 20 Mexico consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 21 MEA consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 22 South Africa consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 23 Saudi Arabia consumer genomics market estimates & forecasts, by application, 2017 - 2028 (USD Million)

List of Figures

  • FIG. 1 Market snapshot
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Total number of people tested by consumer genomics companies, 2013-2018 (in million)
  • FIG. 12 Declining cost of DNA sequencing per genome from 2010-2017
  • FIG. 13 Number of consumer genomics companies with respect to test categories, as of 2015
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for application, 2020
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global consumer genomics market: Application outlook key takeaways
  • FIG. 19 Global consumer genomics market: Application movement analysis
  • FIG. 20 Global consumer genomics market for genetic relatedness, 2017 - 2028 (USD Million)
  • FIG. 21 Global consumer genomics market for diagnostics, 2017 - 2028 (USD Million)
  • FIG. 22 Global consumer genomics market for lifestyle, wellness, & nutrition, 2017 - 2028 (USD Million)
  • FIG. 23 Global consumer genomics market for ancestry, 2017 - 2028 (USD Million)
  • FIG. 24 Global consumer genomics market for reproductive health, 2017 - 2028 (USD Million)
  • FIG. 25 Global consumer genomics market for personalized medicine & pharmacogenetic testing, 2017 - 2028 (USD Million)
  • FIG. 26 Global consumer genomics market for sports nutrition & health, 2017 - 2028 (USD Million)
  • FIG. 27 Global consumer genomics market for others, 2017 - 2028 (USD Million)
  • FIG. 28 Regional market place: Key takeaway
  • FIG. 29 Global consumer genomics market: Regional outlook, 2020 & 2028
  • FIG. 30 Penetration & growth prospect mapping for region, 2020
  • FIG. 31 Consumers' opinions about regulation and the ethics of direct access to genetic testing
  • FIG. 32 North America consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 33 Total number of patients tested by U.S.-based Ancestry DNA company, 2013-2018 (In millions)
  • FIG. 34 Centers for disease Control and Prevention (CDC) authorized articles in the Public Health Genomics Knowledge Base (PHGKB), 2012 - 2016
  • FIG. 35 U.S. consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 36 Canada consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 37 Europe consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 38 Germany consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 39 U.K. consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 40 France consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 41 Italy consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 42 Spain consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 43 Asia Pacific consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 44 Japan consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 45 China consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 46 Australia consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 47 India consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 48 Singapore consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 49 Latin America consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 50 Brazil consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 51 Mexico consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 52 MEA consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 53 South Africa consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 54 Saudi Arabia consumer genomics market, 2017 - 2028 (USD Million)
  • FIG. 55 Strategy framework
  • FIG. 56 Market participant categorization